Caffeic Acid Genotoxicity: Correlation of the Pig‐a Assay with Regulatory Genetic Toxicology In Vivo Endpoints

Caffeic acid is found in variety of fruits and vegetables. It is considered as possible human carcinogen (Group 2B). It is negative in Ames and mouse micronucleus (MN), but positive in mouse lymphoma and chromosomal aberration assays. The objective of this study was to evaluate the in vivo genotoxicity of caffeic acid using three different endpoints: in vivo MN, Pig‐a, and comet assay. Two sets of six rats per group were administered vehicle (0.5% hydroxypropyl methylcellulose), 500, 1,000, or 2,000 mg/kg/day of caffeic acid for three consecutive days via oral gavage. One set of animals was used for the Pig‐a and MN assay and the other set was used for the comet assay. N‐Ethyl N‐Nitrosourea was used as positive control for the Pig‐a and MN assay, and ethyl methanesulfonate for the comet assay. From one set of animals, peripheral blood was collected on Days −1, 14, and 30 for the Pig‐a assay and on Day 4 for the MN assay. The other set of animals was euthanized 3 hr after the last dose; liver and blood were collected for the comet assay. A statistically significant increase in the MN frequency was observed at 2,000 mg/kg/day. No increase in the red blood cells (RBCCD59‐) or reticulocytes (RETCD59‐) Pig‐a mutant frequencies was observed on Days 14 or 30. No increase in DNA strand breaks was observed in the peripheral blood or liver in the comet assay. Environ. Mol. Mutagen. 2019. © 2019 Wiley Periodicals, Inc.

[1]  J. Bemis,et al.  Suitability of Long‐Term Frozen Rat Blood Samples for the Interrogation of Pig‐a Gene Mutation by Flow Cytometry , 2018, Environmental and molecular mutagenesis.

[2]  J. Kujawski,et al.  Supplementary material : Antioxidant properties of several caffeic acid derivatives: A theoretical study , 2017 .

[3]  A. Sutter,et al.  In Vivo Pig‐a gene mutation assay: Guidance for 3Rs‐friendly implementation , 2016, Environmental and molecular mutagenesis.

[4]  K. Witt,et al.  The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

[5]  E. L. Maistro,et al.  In vitro genotoxicity assessment of caffeic, cinnamic and ferulic acids. , 2011, Genetics and molecular research : GMR.

[6]  S. Dertinger,et al.  When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis. , 2011, Mutation research.

[7]  David Kirkland,et al.  Further analysis of Ames-negative rodent carcinogens that are only genotoxic in mammalian cells in vitro at concentrations exceeding 1 mM, including retesting of compounds of concern. , 2010, Mutagenesis.

[8]  A. Scalbert,et al.  Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  E. Oltz,et al.  Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis , 1988, Experientia.

[10]  Young-Chae Chang,et al.  Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  M. Hirose,et al.  Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model. , 1998, Carcinogenesis.

[12]  J. Schlatter,et al.  Dose Response for the Stimulation of Cell Division by Caffeic Acid in Forestomach and Kidney of the Male F344 Rat , 1997 .

[13]  K. Kohn,et al.  Hydroxylated aromatic inhibitors of HIV-1 integrase. , 1995, Journal of medicinal chemistry.

[14]  N. Baber,et al.  International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). , 1994, British journal of clinical pharmacology.

[15]  M. Hirose,et al.  Forestomach and kidney carcinogenicity of caffeic acid in F344 rats and C57BL/6N x C3H/HeN F1 mice. , 1991, Cancer research.

[16]  T. P. Cameron,et al.  Mutagenic activity of some coffee flavor ingredients. , 1988, Mutation research.

[17]  T. Adzet,et al.  Pharmacokinetics of caffeic acid in rats by a high-performance liquid chromatography method. , 1988, Journal of pharmaceutical and biomedical analysis.

[18]  J. Heddle,et al.  Caffeic acid as an inhibitor of DMBA-induced chromosomal breakage in mice assessed by bone-marrow micronucleus test. , 1983, Mutation research.

[19]  H. Stich,et al.  Clastogenic activity of caffeic acid and its relationship to hydrogen peroxide generated during autooxidation. , 1983, Mutation research.